Flaviviridae

Mucocutaneous Manifestations of Viral Diseases

Volumn , Issue , 2002, Pages 473-502

  Weir, Michael R ^a   Weir, Tracey E ^b  

^a SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^b Brackenridge Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 38349171897     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (83)

1. I Kautner, MJ Robinson, U Kuhnle. Dengue virus infection: epidemiology, pathogenesis, clinical presentation, diagnosis, and prevention. J Pediatr 131:516-524, 1997.
2. World Health Organization. Dengue Hemorrhagic Fever: Diagnosis, Treatment and Control. Geneva: World Health Organization, 1986.
3. DW Vaughn, S Green. Dengue and dengue hemorrhagic fever. In: GT Strickland, ed. Hunter’s Tropical Medicine, 8th ed. Philadelphia: WB Saunders, 1991, pp. 240-245.
4. DE Carey. Chikungunya and dengue: a case of mistaken identity. J Hist Med Allied Sci 26:243-262, 1971.
5. NJ Ehrenkranz, AK Ventura, RR Cuadrado, WL Pond, JE Porter. Pandemic dengue in Caribbean countries and the southern United States: past, present and potential problems. N Engl J Med 285:1460-1469, 1971.
6. L Rice. Dengue fever: a clinical report of the Galveston epidemic of 1922. Am J Trop Med Hyg 3:73-90, 1923.
7. WM Hammon, A Rudnik, GE Sather. Viruses associated with epidemic hemorrhagic fevers of the Philippines and Thailand. Science 131:1102-1103, 1960.
8. GF Lumley, FH Taylor. Dengue. School of Public Health and Tropical Medicine Service Publication Number 3. Glebe: Australasian Medical Publishing Company, 1943, p. 74.
9. AB Sabin. The dengue group of viruses and its family relationships. Bacteriol Rev 14:225-232, 1950.
10. AB Sabin. Research on dengue during World War II. Am J Trop Med Hyg 1:30-49, 1952.
11. DJ Gubler, DW Trent. Emergence of the epidemic dengue/dengue hemorrhagic fever as a public health problem in the Americas. Infect Agents Dis 2:383-393, 1994.
12. SB Halstead. The pathogenesis of dengue. Am J Epidemiol 114:632-648, 1981.
13. SB Halstead. Observations related to pathogenesis of dengue hemorrhagic fever. VI. Hypothesis and discussion. Yale J Biol Med 42:350-362, 1970.
14. CG Hayes, TF O’Rourke, V Fogelman, DD Leavengood, G Crow, MM Albersmeyer. Dengue fever in American military personnel in the Phillippines: clinical observations on hospitalized patients during a 1984 epidemic. Southeast Asian J Trop Med Public Health 20:1-8, 1989.
15. EB Hayes, DJ Gubler. Dengue and dengue hemorrhagic fever. Pediatr Infect Dis J 11:311-317, 1992.
16. SK Lam. Dengue and dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health 21:520-521, 1990.
17. JG Rigau-Perez, GG Clark, DJ Gubler, P Reiter, EJ Sanders, AV Vorndam. Dengue and dengue haemorrhagic fever. Lancet 352:971-977, 1998.
18. DJ Gubler. Question and Answers About DHF. Atlanta: Centers for Disease Control and Prevention, August 1995, pp. 1-9.
19. ER Nelson. Dengue fever: a thrombocytopenic disease? JAMA 190:99-103, 1964.
20. N Bhamarapravati, P Toochinda, V Boonyapaknavik. Pathology of Thailand hemorrhagic fever: a study of 100 autopsy cases. Ann Trop Med Parasitol 61:500-510, 1967.
21. RM de Andino, MV Botet, DJ Gubler, C Garcia, E Laboy, F Espada, SH Waterman. The absence of dengue virus in the skin lesions of dengue fever. Int J Dermatol 24:48-51, 1985.
22. JH McBride. Dengue fever: an Australian perspective. Aust Fam Physician 28:319-323, 1999.
23. BL Innis, A Nisalak, S Nimmanitya, S Kusalerdchariya, V Chongswasdi, S Suntayakorn, P Puttisri, CH Hoke. An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis cocirculate. Am J Trop Med Hyg 40:418-427, 1989.
24. S Tassniyom, S Vasanawathana, A Chirawatkul, S Rojanasuphot. Failure of high-dose methylprednisolone in established dengue shock syndrome: a placebo-controlled, double-blind study. Pediatrics 92:111-115, 1993.
25. TP Monath, FX Heinz. Flaviruses. In: FN Fields, DM Knipe, PM Howley, et al., eds. Fields Virology, 3rd ed. Philadelphia: Lippincott-Raven, 1996, pp. 961-1034.
26. R Inada. Compute rendu des recherches sur l’encephalite epidemique au Japon. Offic Internat d’Hyg Pub Bull Mens 29:1389-1401, 1937.
27. WF Scherer, EL Buescher. Ecologic studies of Japanese encephalitis in Japan. Parts I-IX. Am J Trop Med Hyg 8: 644-722, 1959.
28. World Health Organization. Japanese Encephalitis Vaccines, position paper. Geneva: World Health Organization, updated Jan 18, 1999.
29. MW Benenson, FJ Top Jr., W Gresso, CW Ames, LB Altstatt. The virulence to man of Japanese encephalitis virus in Thailand. Am J Trop Med Hyg 24:974-980, 1975.
30. B Dropulic, CL Masters. Entry of neurotropic arboviruses into the central nervous system: an in vitro study using brain endothelium. J Infect Dis 161:685-691, 1990.
31. R Kumar, A Mathur, KB Singh, P Sitholey, M Prasad, R Shukla, SP Agarwal, J Arockiasamy. Clinical sequelae of Japanese encephalitis in children. Indian J Med Res 97: 9-13, 1993.
32. TF Tsai. Japanese encephalitis vaccines. In: S Plotkin, ed. Vaccines, 2nd ed. Philadelphia: WB Saunders, 1994, pp. 671-713.
33. K Hayashi, T Arita. Experimental double infection of Japanese encephalitis virus and herpes simplex in mouse brain. Jpn J Exp Med 47:9-13, 1977.
34. RT Johnson, DS Burke, M Elwell, CJ Leake, A Nisalak, CH Hoke, W Lorsomrudee. Japanese encephalitis: immuno-cytochemical studies of viral antigen and inflammatory cells in fatal cases. Ann Neurol 18:567-573, 1985.
35. CH Hoke Jr., DW Vaughn, A Nisalak, P Intralawan, S Pools-uppasit, V Jongsawas, U Titsyakorn, RT Johnson. Effect of high-dose dexamethasone on the outcome of acute encephalitis due to Japanese encephalitis virus. J Infect Dis 165: 631-637, 1992.
36. TH Work. Russian spring-summer virus in India. Kyasanur Forest disease. Prog Med Virol 1:248-279, 1958.
37. PN Bhatt, TH Work, MG Varma, H Trapido, DP Murthy, FM Rodrigues. Kyasanur forest diseases. IV. Isolation of Kyasanur forest disease virus from infected humans and monkeys of Shimogadistrict, Mysore state. Indian J Med Sci 20:316-320, 1966.
38. TH Work, FR Rodriquez, PN Bhatt. Kyasanur forest disease: virological epidemiology of the 1958 epidemic. Am J Public Health 49:869-874, 1959.
39. MJ Boshell, Rajagopalan PK, Patil AP, Pavri KM. Isolation of Kyasanur Forest disease virus from ixodid ticks: 1961-1964. Indian J Med Res 56:541-568, 1968.
40. World Health Organization. Viral haemorrhagic fevers. World Health Org Tech Rep Ser 721:5-126, 1985.
41. K Pavri. Clinical, clinicopathologic, and hematologic features of Kyasanur Forest disease Rev Infect Dis 11(suppl 4):S854-S859, 1989.
42. MR Prabha, MG Prabhu, CV Raghuveer, M Bai, MA Mala. Clinical study of 100 cases of Kyasanur Forest disease with clinicopathological correlation. Indian J Med Sci 47: 124-130, 1993.
43. CG Iyer, RR Laxmana, TH Work, DP Narasimha Murthy. Kyasanur forest disease VI. Pathologic findings in 3 fatal human cases of Kyasanur Forest Disease. Indian J Med Sci 13:1011-1022, 1959.
44. NN Kharitonova, YA Leonov. Omsk Hemorrhagic Fever. Ecology of the Agent and Epizootiology. New Delhi: Amerind Publishing Company, 1985.
45. BD Schoub, NK Blackburn. Flaviviruses. In: AJ Zucker-man, JE Banatvala, JR Pattison, eds. Principles and Practice of Clinical Virology, 3rd ed. Chichester: John Wiley & Sons, 1994, pp. 512-513.
46. AS Benenson, ed. Control of Communicable Diseases Manual: An Official Report of the American Public Health Association, 16th ed. Washington, DC. The Association, 1995, pp. 25-54.
47. TF Tsai. Arboviral infections in the United States. Infect Dis Clin North Am 5:73-102, 1991.
48. National Center for Infectious Diseases. Information on Ar-boviral Encephalitides. Atlanta: Centers for Disease Control and Prevention. Available at: http://www.cdc.gov/ncidod/dvbid/arbor/arbdet.htm. Accessed Feb 13, 2000.
49. A Gonzalez Cortes, ML Zarate Aquino, JG Bahena Guzman, J Miro Abella, G Cano Avila, M Aguilera Arrayo. St. Louis encephalomyelitis in Hermosillo, Sonora, Mexico. Pan Am Health Org Bull 9:306-316, 1975.
50. RS Nasci, CG Moore. Vector-borne disease surveillance and natural disasters. Emerg Infect Dis 4:333-334, 1998.
51. A Desai, SK Shankar, V Revi, A Chandramuki, M Gourie-Devi. Japanese encephalitis virus antigen in the human brain and its topographic distribution. Acta Neuropathol 89: 368-373, 1995.
52. RM Zwighaft, C Rasmussen, D Brolnitsky, JC Lashof. St. Louis encephalitis: the Chicago experience. Am J Trop Med Hyg 28:114-118, 1979.
53. DT Quick, JM Thompson, JO Bond. The 1962 epidemic of St. Louis encephalitis in Florida. IV. Clinical features of cases in the Tampa Bay area. Am J Epidemiol 81:415-427, 1965.
54. RJ Whitley. Arthropod-borne encephalitides. In: WM Scheld, RJ Whitley, DT Durack, eds. Infections of the Central Nervous System, 2nd ed. Philadelphia: Lippincott-Raven, 1997, pp. 147-168.
55. AA Smorodintsev. Tick-borne spring-summer encephalitis. Prog Med Virol 1:210-248, 1958.
56. D Blaskovic, G Pucekova, L Kubinyi. An epidemiological study of tick-borne encephalitis in the Tribec region: 1956-1963. Bull World Health Organ 36:89-94, 1967.
57. V Danielova, C Benes. Possible role of rainfall in the epidemiology of tick-borne encephalitis. Cent Eur J Public Health 5:151-154, 1997.
58. DH Clarke, J Casals. Arboviruses group B. In: FL Horsfall, I Tanner, eds. Viral and Rickettsial Infection of Man. Philadelphia: JB Lippincott, 1965, pp. 606-658.
59. WF Scherer, GA Eddy, TP Monath, et al. Laboratory safety for arboviruses and certain other viruses of vertebrates. The Subcommittee on Arbovirus Laboratory Safety of the American Committee on Arthropod-Borne Viruses. Am J Trop Med Hyg 29:1359-1381, 1980.
60. IB Galant. Certain features of the course of contemporary Far Eastern tick-borne encephalitis. Prob Virol 4:66-68, 1959.
61. M Labuda, JM Austyn, E Zuffova, O Kozuch, N Fuchsberger, J Lysy, PA Nuttall. Importance of localized skin infection in tick-borne encephalitis virus transmission. Virology 219:357-366, 1996.
62. G Gunther, M Hahlund, L Lindquist, B Skoldenberg, M Forsgren. Intrathecal IgM, IgA and IgG antibody response in tick-borne encephalitis. Long-term follow-up related to clinical course and outcome. Clin Diagn Virol 8:17-29, 1997.
63. TR Kreil, MM Eibl. Viral infection of macrophages profoundly alters requirements for induction of nitric oxide synthesis. Virology 212:174-178, 1995.
64. S Lotric-Furlan, F Strle. Thrombocytopenia, leukopenia and abnormal liver function tests in the initial phase of tickborne encephalitis. Zentralbl Bakteriol 282:275-278,1995.
65. T Jeren, A Vince. Cytologic and immunoenzymatic findings in CSF from patients with tick-borne encephalitis. Acta Cytol 42:330-334, 1998.
66. LA Zilber, VD Soloviev. Far Eastern tick-borne springsummer encephalitis. Annu Rev Med Spec 5(suppl):1-75, 1946.
67. H Hofmann, C Kunz, FX Heinz. Laboratory diagnosis of tick-borne encephalitis. Arch Virol 1(suppl):153-159, 1990.
68. M Roggendorf, F Heinz, F Deinhardt, C Kunz. Serological diagnosis of acute tick-borne encephalitis by demonstration of antibodies of the IgM class. J Med Virol 7:41-50, 1981.
69. H Hofmann, C Kunz, FX Heinz, H Dippe. Detectability of IgM antibodies against TBE virus after natural infection and after vaccination. Infection 11:164-166, 1983.
70. FX Heinz, M Roggendorf, H Hofmann, C Kunz, F Dienhardt. Comparison of two different enzyme immunoassays for detection of immunoglobulin M antibodies against tickborne encephalitis virus in serum and cerebrospinal fluid. J Clin Microbiol 14:141-146, 1981.
71. G Kluger, A Schottler, K Waldvogel, D Nadal, W Hinrichs, GF Wundisch, MC Laub. Tickborne encephalitis despite specific immunoglobulin prophylaxis [letter]. Lancet 346: 1502, 1995.
72. C Kunz. Tick-borne encephalitis in Europe. Acta Leidensia 60:1-14, 1992.
73. HE Webb, JH Connolly, FF Kane, KJ O’Reilly, DI Simpson. Laboratory infections with louping ill with associated encephalitis. Lancet 2:255-258, 1968.
74. JH Lawson, WG Mauderson, EW Hurst. Louping ill meningoencephalitis. A further case and a serologic survey. Lancet 2:696-699, 1949.
75. HW Reid. Louping ILL. In: Monath, ed. The Arboviruses: Epidemiology and Ecology, vol 3. Boca Raton: RC Press, 1988, pp. 118-135.
76. GF Gao, MH Hussain, HW Reid, EA Gould. Classification of a new member of the TBE flavivirus subgroup by its immunological, pathogenetic and molecular characteristics: identification of subgroup-specific pentapeptides. Virus Res 30:129-144, 1993.
77. FL Soper. Jungle yellow fever: new epidemiological entity in South America. Rev Hyg Saude Publica 10:107-144, 1936.
78. World Health Organization. Prevention and Control of Yellow Fever in Africa. Geneva: World Health Organization, 1986.
79. National Center for Infectious Diseases. Summary of Health Information for International Travel (The Blue Sheet). Atlanta: Centers for Disease Control and Prevention. Available at: http://www.cdc.gov/travel/bluesheet.htm. Accessed Feb 13, 2000.
80. M Germain, M Cornet, J Mouchet, JP Herve, V Robert, JL Camicas, R Cordellier, JP Hervy, JP Digoutte, TP Monath, JJ Salaun, V Deubel, Y Robin, J Coz, R Taufflieb, JF Saluzzo, JP Gonzalez. [Sylvatic yellow fever in Africa recent advances and present approach (author’s transl)]. Med Trop (Mars) 41:31-43, 1981.
81. AS Benenson, ed. Control of Communicable Disease Manual: An Official Report of the American Public Health Association, 16th ed. Washington D.C.: The Association, 1995, pp. 519-524.
82. D Brandling-Bennett, F Pinheiro. Infectious diseases in Latin America and the Caribbean: are they really emerging and increasing? Emerg Infect Dis 2:59-61, 1996.
83. JM McFarland, LM Baddour, JE Nelson, SK Elkins, RB Craven, BC Cropp, GJ Chang, AD Grindstaff, AS Craig, RJ Smith. Imported yellow fever in a United States citizen. Clin Infect Dis 25:1143-1147, 1997.